Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation

被引:0
|
作者
Buldini, Barbara [1 ]
Merli, Pietro [2 ]
Varotto, Elena [1 ,3 ]
Masetti, Riccardo [4 ]
Gabelli, Maria [1 ]
Zecca, Marco [5 ]
Fagioli, Franca [6 ]
Scarparo, Pamela [1 ]
Algeri, Mattia [2 ]
Biffi, Alessandra [7 ]
Pigazzi, Martina [8 ]
Pagliara, Daria [2 ]
Locatelli, Franco [9 ,10 ]
机构
[1] Univ Padua, Pediat Hematol Oncol & Stem Cell Transplant Div, Maternal & Child Hlth Dept, Padua, Italy
[2] Bambino Gesu Children Hosp, Dept Haematol Oncol & Cell & Gene Therapy, Rome, Italy
[3] Univ Padua, Padua, Italy
[4] Dept P, Pediat Oncol & Hematol Unit lalla Seragnoli, Bologna, Italy
[5] Fdn IRCCS Policlin San Matteo, Pediat Hematol Oncol, Pavia, Italy
[6] Univ Turin, Regina Margherita Childrens Hosp, Pediat Onco Hematol Stem Cell Transplantat & Cell, Turin, Italy
[7] Padua Univ Hosp, Pediat Hematol Oncol & Stem Cell Transplant Div, Padua, Italy
[8] Univ Padua, Dept Womens & Childrens Hlth, Oncohematol Lab & Clin, Padua, Italy
[9] Univ Cattolica Sacro Cuore, Dept Pediat Hematol & Oncol, IRCCS Osped Pediatr Bambino Gesu, Rome, Italy
[10] Univ Cattolica Sacro Cuore, Bambino Gesu Childrens Hosp, Rome, Italy
关键词
D O I
10.1182/blood-2023-189080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia
    Marques, Carolina Perrone
    de Almeida Silveira, Ana Carolina
    Zezzi, Jade
    Batista Chaves, Felipe Galvao
    da Rocha, Juliana Dall'Agnol
    Stanzione, Renata Leati
    Kerbauy, Mariana Nassif
    Hamerschlak, Nelson
    Santos, Fabio P. S.
    Arcuri, Leonardo Javier
    Ribeiro, Andreza Feitosa
    BLOOD, 2023, 142
  • [2] Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
    Morsink, Linde M.
    Sandmaier, Brenda M.
    Othus, Megan
    Palmieri, Raffaele
    Granot, Noa
    Bezerra, Evandro D.
    Wood, Brent L.
    Mielcarek, Marco
    Schoch, Gary
    Davis, Chris
    Flowers, Mary E. D.
    Deeg, H. Joachim
    Appelbaum, Frederick R.
    Storb, Rainer
    Walter, Roland B.
    CANCERS, 2020, 12 (09) : 1 - 18
  • [3] Fast-Track Measurable Residual Disease Detection By Multiparametric Flow Cytometry in Acute Myeloid Leukemia before Allogeneic Hematopoietic Cell Transplantation
    Roehnert, Maximilian Alexander
    Kramer, Michael
    Schadt, Jonas
    Ensel, Philipp
    Roellig, Christoph
    Schetelig, Johannes
    Stoelzel, Friedrich
    Bornhaeuser, Martin
    Oelschlaegel, Uta
    von Bonin, Malte
    BLOOD, 2022, 140 : 11824 - 11826
  • [4] Pre-Transplant Multiparameter Flow Cytometric Measurable Residual Disease in Acute Myeloid Leukemia As an Independent Prognostic Factor for Survival after Myeloablative Allogeneic Hematopoietic Cell Transplantation
    Czyz, Anna
    Kruszelnicka, Malgorzata Maria Sobczyk
    Czerw, Tomasz
    Giebel, Sebastian
    Dutka, Magdalena
    Piekarska, Agnieszka
    Bieniaszewska, Maria
    Zaucha, Jan
    Majcherek, Maciej
    Sobas, Marta Anna
    Wrobel, Tomasz
    Nasilowska-Adamska, Barbara
    Kazimierz, Halaburda
    Szczepaniak, Andrzej
    Gil, Lidia
    Kopinska, Anna
    Helbig, Grzegorz
    Bartyzel-Palinska, Sylwia
    Mensah-Glanowska, Patrycja
    Tomaszewska, Agnieszka
    Pluta, Agnieszka
    Patkowska, Elzbieta
    Wozniak, Jolanta
    Balana, Agnieszka
    Szymczak, Donata
    Parulska, Jolanta
    Sukkur, Ameenah
    Rustani, Andi
    Trinchant, Nuria Mencia
    Desai, Pinkal
    Samuel, Michael
    Kaner, Justin D.
    Ritchie, Ellen
    Guzman, Monica L.
    Roboz, Gail J.
    Wierzbowska, Agnieszka
    BLOOD, 2022, 140 : 7747 - 7749
  • [5] An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data
    Li, Chi-Cheng
    Ko, Bor-Sheng
    Wang, Yu-Fen
    Li, Jeng-Lin
    Weng, Pei-Fang
    Hou, Hsin-An
    Liao, Xiu-Wen
    Lin, Chien-Ting
    Liu, Jia-Hou
    Sun, Hsun-I
    Tien, Hwei-Fang
    Lee, Chi-Chun
    Tang, Jih-Luh
    BLOOD, 2017, 130
  • [6] Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
    Sahin, U.
    Erdal, H.
    Bozdag, S. Civriz
    Toprak, S. K.
    Yuksel, M. Kurt
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Demirer, T.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Konuk, N.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S482 - S483
  • [7] Combination of NCCN Risk Stratification System and Pre-Transplant Minimal Residual Disease Levels for the Prognosis of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Li, Yahan
    Sun, Xue
    Wang, Xin
    Fang, Xiaosheng
    BLOOD, 2021, 138
  • [8] Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
    Stahl, Maximilian
    Derkach, Andriy
    Famulare, Christopher
    Cho, Christina
    Devlin, Sean
    Farnoud, Noushin
    Menghrajani, Kamal
    Patel, Minal A.
    Cai, Sheng F.
    Geyer, Mark B.
    Dunbar, Andrew
    Epstein-Peterson, Zachary D.
    McGovern, Erin
    Schulman, Jessica
    Glass, Jacob L.
    Taylor, Justin
    Viny, Aaron D.
    Stein, Eytan M.
    Getta, Bartlomiej
    Arcila, Maria E.
    Levine, Ross L.
    Barker, Juliet
    Shaffer, Brian C.
    Papadopoulos, Esperanza B.
    Gyurkocza, Boglarka
    Perales, Miguel-Angel
    Abdel-Wahab, Omar
    Papaemmanuil, Elli
    Giralt, Sergio A.
    Zhang, Yanming
    Roshal, Mikhail
    Tallman, Martin S.
    Goldberg, Aaron D.
    BLOOD, 2020, 136
  • [9] Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation
    Guolo, Fabio
    Di Grazia, Carmen
    Minetto, Paola
    Raiola, Anna Maria
    Clavio, Marino
    Miglino, Maurizio
    Tedone, Elisabetta
    Contini, Paola
    Mangerini, Rosa
    Kunkl, Annalisa
    Colombo, Nicoletta
    Pugliese, Girolamo
    Carminati, Enrico
    Marcolin, Riccardo
    Passannante, Monica
    Bagnasco, Samuele
    Galaverna, Federica
    Lamparelli, Teresa
    Ballerini, Filippo
    Cagnetta, Antonia
    Cea, Michele
    Gobbi, Marco
    Bacigalupo, Andrea
    Lemoli, Roberto Massimo
    Angelucci, Emanuele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (05) : 573 - 582
  • [10] Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML
    Klyuchnikov, Evgeny
    Christopeit, Maximilian
    Badbaran, Anita
    Bacher, Ulrike
    Fritzsche-Friedland, Ulrike
    von Pein, Ute-Marie
    Wolschke, Christine
    Kroeger, Nicolaus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (05) : 606 - 615